{"id":38981,"date":"2017-05-09T06:24:52","date_gmt":"2017-05-09T10:24:52","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=38981"},"modified":"2017-05-09T03:26:12","modified_gmt":"2017-05-09T07:26:12","slug":"array-biopharma-inc-nasdaqarrys-board-of-directors-brings-on-board-shalini-sharp","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/array-biopharma-inc-nasdaqarrys-board-of-directors-brings-on-board-shalini-sharp-38981","title":{"rendered":"Array Biopharma Inc (NASDAQ:ARRY)\u2019s Board of Directors Brings on board Shalini Sharp"},"content":{"rendered":"<p style=\"text-align: justify;\"><strong>Array Biopharma Inc <\/strong><strong>(NASDAQ:ARRY) <\/strong>has today come forward to announce that Shalini Sharp, the Chief Financial Officer who is at the same time <strong>Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)<\/strong>\u2019s Executive Vice President move to work with the provider\u2019s Board of Directors.<\/p>\n<p style=\"text-align: justify;\">This happened in April 27, 2017 and according to close sources, the entry spells a lot of good things in future for this company. She will most probably be a part of the board\u2019s Audit Committee\u00a0and this comes in a wake when the company is doing all within it means to revamp its services.<\/p>\n<p style=\"text-align: justify;\">The new top executive has worked in different companies and helped push them a notch higher in terms of business success. For instance, she will be remembered for her good work at Ultragenyx, which is of course a biopharmaceutical provider that majorly deals in coming up with top solutions to help face out rare diseases.<\/p>\n<p style=\"text-align: justify;\">For an elongated period time, Ms. Sharp has led the corporate finance,\u00a0information technology functions and the strategy section and that added to her experience in serving as a member of the company\u2019s executive leadership team is for sure a huge deal for any company dealing in providing related services. It is for sure great news that she is actually moving into the life sciences industry bringing about some twenty years working experience.<\/p>\n<p style=\"text-align: justify;\">The Chief Executive Officer of Array, Ron Squarerin making a statement said, \u201cShalini has an ideal background to complement the expertise of our Board of Directors. Her financial leadership at healthcare organizations will be invaluable as we focus our efforts in oncology and prepare for commercialization.&#8221;<\/p>\n<p style=\"text-align: justify;\">When it came to Ms. Sharp turn to speak, she should her great excitement in being given the honor to work for the top provider. She proceeded, &#8220;Array has built an impressive development pipeline of therapeutics that is advancing in late-stage clinical trials and provides the opportunity to significantly benefit patients in areas of unmet need. I&#8217;m excited to join the company&#8217;s Board at such an important time in its history, as it nears commercialization of its drugs. I look forward to working with Ron and my fellow Board members through this important evolution of Array.&#8221;<\/p>\n<p style=\"text-align: justify;\">There is much hope that the new leader will help the company make tremendous steps forward. However, this is just something we have to wait and see.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Array Biopharma Inc (NASDAQ:ARRY) has today come forward to announce that Shalini Sharp, the Chief Financial Officer who is at the same time Ultragenyx Pharmaceutical [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":38988,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[12612,2719,12614,12615,358,2720,7469,12613,7468],"stock_ticker":[],"class_list":["post-38981","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-array-biopharma-inc","tag-array-biopharma-inc-nasdaqarry","tag-array-biopharma-inc-nasdaqarry-has-today-come-forward-to-announce-that-shalini-sharp-the-chief-financial-officer-who-is-at-the-same-time-ultragenyx-pharmaceutical-inc-nasdaqrare","tag-arry","tag-nasdaq","tag-nasdaqarry","tag-nasdaqrare","tag-ultragenyx-pharmaceutical-inc","tag-ultragenyx-pharmaceutical-inc-nasdaqrare","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Array Biopharma Inc (NASDAQ:ARRY)\u2019s Board of Directors Brings on board Shalini Sharp - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/array-biopharma-inc-nasdaqarrys-board-of-directors-brings-on-board-shalini-sharp-38981\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Array Biopharma Inc (NASDAQ:ARRY)\u2019s Board of Directors Brings on board Shalini Sharp - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Array Biopharma Inc (NASDAQ:ARRY) has today come forward to announce that Shalini Sharp, the Chief Financial Officer who is at the same time Ultragenyx Pharmaceutical [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/array-biopharma-inc-nasdaqarrys-board-of-directors-brings-on-board-shalini-sharp-38981\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-05-09T10:24:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/38987-penny_stocks.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"669\" \/>\n\t<meta property=\"og:image:height\" content=\"377\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Van Bettauer\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Van Bettauer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/array-biopharma-inc-nasdaqarrys-board-of-directors-brings-on-board-shalini-sharp-38981#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/array-biopharma-inc-nasdaqarrys-board-of-directors-brings-on-board-shalini-sharp-38981\"},\"author\":{\"name\":\"Van Bettauer\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d\"},\"headline\":\"Array Biopharma Inc (NASDAQ:ARRY)\u2019s Board of Directors Brings on board Shalini Sharp\",\"datePublished\":\"2017-05-09T10:24:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/array-biopharma-inc-nasdaqarrys-board-of-directors-brings-on-board-shalini-sharp-38981\"},\"wordCount\":409,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/array-biopharma-inc-nasdaqarrys-board-of-directors-brings-on-board-shalini-sharp-38981#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/38987-penny_stocks.jpg\",\"keywords\":[\"Array Biopharma Inc\",\"Array Biopharma Inc (NASDAQ:ARRY)\",\"Array Biopharma Inc (NASDAQ:ARRY) has today come forward to announce that Shalini Sharp the Chief Financial Officer who is at the same time Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)\",\"ARRY\",\"NASDAQ\",\"NASDAQ:ARRY\",\"NASDAQ:RARE\",\"Ultragenyx Pharmaceutical Inc\",\"Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/array-biopharma-inc-nasdaqarrys-board-of-directors-brings-on-board-shalini-sharp-38981#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/array-biopharma-inc-nasdaqarrys-board-of-directors-brings-on-board-shalini-sharp-38981\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/array-biopharma-inc-nasdaqarrys-board-of-directors-brings-on-board-shalini-sharp-38981\",\"name\":\"Array Biopharma Inc (NASDAQ:ARRY)\u2019s Board of Directors Brings on board Shalini Sharp - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/array-biopharma-inc-nasdaqarrys-board-of-directors-brings-on-board-shalini-sharp-38981#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/array-biopharma-inc-nasdaqarrys-board-of-directors-brings-on-board-shalini-sharp-38981#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/38987-penny_stocks.jpg\",\"datePublished\":\"2017-05-09T10:24:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/array-biopharma-inc-nasdaqarrys-board-of-directors-brings-on-board-shalini-sharp-38981#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/array-biopharma-inc-nasdaqarrys-board-of-directors-brings-on-board-shalini-sharp-38981\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/array-biopharma-inc-nasdaqarrys-board-of-directors-brings-on-board-shalini-sharp-38981#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/38987-penny_stocks.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/38987-penny_stocks.jpg\",\"width\":669,\"height\":377},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/array-biopharma-inc-nasdaqarrys-board-of-directors-brings-on-board-shalini-sharp-38981#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Array Biopharma Inc (NASDAQ:ARRY)\u2019s Board of Directors Brings on board Shalini Sharp\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d\",\"name\":\"Van Bettauer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g\",\"caption\":\"Van Bettauer\"},\"description\":\"Van Bettauer is a financial aficionado from Vancouver, British Columbia. He currently studies at UBC, pursuing a Bachelors of Science degree. Van has been freelance writing for many years, specializing in copywriting, report writing and article writing. The combination of his scientific studies and writing experience brings a new and fresh perspective to the financial world. Visit Bettauer's Google+ page at the following address: https:\/\/plus.google.com\/100770875710593766367\/posts\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/van-bettauer\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Array Biopharma Inc (NASDAQ:ARRY)\u2019s Board of Directors Brings on board Shalini Sharp - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/array-biopharma-inc-nasdaqarrys-board-of-directors-brings-on-board-shalini-sharp-38981","og_locale":"en_US","og_type":"article","og_title":"Array Biopharma Inc (NASDAQ:ARRY)\u2019s Board of Directors Brings on board Shalini Sharp - Wall Street PR","og_description":"Array Biopharma Inc (NASDAQ:ARRY) has today come forward to announce that Shalini Sharp, the Chief Financial Officer who is at the same time Ultragenyx Pharmaceutical [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/array-biopharma-inc-nasdaqarrys-board-of-directors-brings-on-board-shalini-sharp-38981","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2017-05-09T10:24:52+00:00","og_image":[{"width":669,"height":377,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/38987-penny_stocks.jpg","type":"image\/jpeg"}],"author":"Van Bettauer","twitter_misc":{"Written by":"Van Bettauer","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/array-biopharma-inc-nasdaqarrys-board-of-directors-brings-on-board-shalini-sharp-38981#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/array-biopharma-inc-nasdaqarrys-board-of-directors-brings-on-board-shalini-sharp-38981"},"author":{"name":"Van Bettauer","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d"},"headline":"Array Biopharma Inc (NASDAQ:ARRY)\u2019s Board of Directors Brings on board Shalini Sharp","datePublished":"2017-05-09T10:24:52+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/array-biopharma-inc-nasdaqarrys-board-of-directors-brings-on-board-shalini-sharp-38981"},"wordCount":409,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/array-biopharma-inc-nasdaqarrys-board-of-directors-brings-on-board-shalini-sharp-38981#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/38987-penny_stocks.jpg","keywords":["Array Biopharma Inc","Array Biopharma Inc (NASDAQ:ARRY)","Array Biopharma Inc (NASDAQ:ARRY) has today come forward to announce that Shalini Sharp the Chief Financial Officer who is at the same time Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)","ARRY","NASDAQ","NASDAQ:ARRY","NASDAQ:RARE","Ultragenyx Pharmaceutical Inc","Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/array-biopharma-inc-nasdaqarrys-board-of-directors-brings-on-board-shalini-sharp-38981#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/array-biopharma-inc-nasdaqarrys-board-of-directors-brings-on-board-shalini-sharp-38981","url":"https:\/\/cablemanpro.com\/wallstreetpr\/array-biopharma-inc-nasdaqarrys-board-of-directors-brings-on-board-shalini-sharp-38981","name":"Array Biopharma Inc (NASDAQ:ARRY)\u2019s Board of Directors Brings on board Shalini Sharp - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/array-biopharma-inc-nasdaqarrys-board-of-directors-brings-on-board-shalini-sharp-38981#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/array-biopharma-inc-nasdaqarrys-board-of-directors-brings-on-board-shalini-sharp-38981#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/38987-penny_stocks.jpg","datePublished":"2017-05-09T10:24:52+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/array-biopharma-inc-nasdaqarrys-board-of-directors-brings-on-board-shalini-sharp-38981#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/array-biopharma-inc-nasdaqarrys-board-of-directors-brings-on-board-shalini-sharp-38981"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/array-biopharma-inc-nasdaqarrys-board-of-directors-brings-on-board-shalini-sharp-38981#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/38987-penny_stocks.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/38987-penny_stocks.jpg","width":669,"height":377},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/array-biopharma-inc-nasdaqarrys-board-of-directors-brings-on-board-shalini-sharp-38981#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Array Biopharma Inc (NASDAQ:ARRY)\u2019s Board of Directors Brings on board Shalini Sharp"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d","name":"Van Bettauer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g","caption":"Van Bettauer"},"description":"Van Bettauer is a financial aficionado from Vancouver, British Columbia. He currently studies at UBC, pursuing a Bachelors of Science degree. Van has been freelance writing for many years, specializing in copywriting, report writing and article writing. The combination of his scientific studies and writing experience brings a new and fresh perspective to the financial world. Visit Bettauer's Google+ page at the following address: https:\/\/plus.google.com\/100770875710593766367\/posts","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/van-bettauer"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/38981","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=38981"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/38981\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/38988"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=38981"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=38981"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=38981"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=38981"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}